JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 55 filers reported holding JANUX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $102,920,544 | 1.94% |
| BVF INC/IL | 4,106,945 | $48,749,437 | 1.36% |
| Samsara BioCapital, LLC | 360,414 | $4,278,114 | 0.75% |
| Orbimed Advisors | 2,836,386 | $33,667,902 | 0.61% |
| EcoR1 Capital, LLC | 452,590 | $5,372,243 | 0.13% |
| XTX Topco Ltd | 13,215 | $156,862 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,683,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,629,751 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,109,338 | $25,031,210 | 0.02% |
| FMR LLC | 5,062,796 | $60,095,389 | 0.01% |
| Jump Financial, LLC | 10,821 | $128,446 | 0.01% |
| Citadel Advisors | 2,115,574 | $25,111,864 | 0.01% |
| Cerity Partners LLC | 60,933 | $723,275 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 10,010 | $118,819 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 8,324 | $98,806 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 1,004 | $11,917 | 0.00% |
| Squarepoint Ops LLC | 27,780 | $329,749 | 0.00% |
| DekaBank Deutsche Girozentrale | 49,500 | $571 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,597 | $18,956 | 0.00% |
| Qube Research & Technologies Ltd | 12,641 | $150,049 | 0.00% |
External links
This page lists JANUX THERAPEUTICS INC's shareholders in Q2 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.